Silencing miR-16 Expression Promotes Angiotensin II Stimulated Vascular Smooth Muscle Cell Growth.

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
• Dysregulated miRNA expression is linked to various human diseases, notably cardiovascular diseases.
• miRNAs influence vascular smooth muscle cell (VSMC) functions, impacting conditions like hypertension and atherosclerosis.

Purpose of the Study:

• To investigate the role of miR-16 in angiotensin II (Ang II)-mediated signaling pathways in VSMCs.
• To determine the effect of miR-16 modulation on Ang II-induced VSMC proliferation and migration.
• To explore miR-16 as a potential therapeutic target for cardiovascular diseases.

Main Methods:

• Quantitative analysis of miR-16 expression in VSMCs.
• Lentiviral vector-mediated knockdown of miR-16.
• Assessment of VSMC proliferation and migration assays.
• Analysis of cell cycle-associated gene expression and activation of ERK1/2 and p38 pathways.

Main Results:

• Angiotensin II (Ang II) was found to downregulate miR-16 expression in VSMCs.
• miR-16 knockdown significantly enhanced Ang II-induced VSMC proliferation and migration.
• Silencing miR-16 potentiated Ang II-mediated upregulation of cell cycle genes and activation of ERK1/2 and p38 pathways.

Conclusions:

• miR-16 plays a critical role in regulating VSMC responses to Ang II.
• Downregulation of miR-16 contributes to Ang II-induced VSMC proliferation and migration.
• miR-16 emerges as a potential therapeutic target for cardiovascular diseases involving Ang II signaling.